This application's goal is the creation of a Cervical Cancer Data &Research Unit, within an existing PROSPR Center, that can completely evaluate the cervical cancer screening process and actively engage in PROSPR collaborative projects. Cervical cancer is largely preventable with appropriate screening, yet the implementation of new techniques, such as human papilloma virus (HPV) testing, has created important challenges regarding how to: optimize new screening methods, minimize screening failures by understanding how and why they occur;and diminish overscreening (since, for >99% of women, screening results in only worry and risk). The proposed Unit, within an existing productive PROSPR collaboration of Kaiser Permanente Northern California and Southern California, can address these critical questions using three strengths. 1) A very large community-based cohort with, for the years 2010-2013 alone: >4.8 million screening eligible women;marked demographic diversity (>1,330,000 Hispanic, 589,000 Asian, and 390,000 African American members);detailed screening data (>2.7 million Pap smears, 2.1 million HPV tests, and 600,000 HPV vaccinations);large numbers of rare outcomes (>800 invasive cancers);socioeconomic diversity (including >54,000 with safety-net payors such as Medicaid);health plan and provider diversity (>35 medical centers, >4000 primary care/OB-GYN physicians throughout California);and a full spectrum of high-quality individual cancer risk data within readily accessible electronic laboratory, pharmacy and pathology data sources extending to before 2005. 2) A successful existing PROSPR colorectal cancer center that has been productive within and across the PROSPR network, delivered this year 192 different screening data elements on almost 2.6 million screening-eligible patients, co-led the development of new data elements across PROSPR centers for exam indications and comorbidities and already published high impact PROSPR manuscripts. 3) An expert team in cervical cancer screening, led by two co-Principal Investigators funded in cervical cancer screening research, complemented by a transdisciplinary group of researchers and expert consultants in obstetrics/gynecology, cancer and infectious disease epidemiology, oncology, pathology, modeling, cohort biostatistics, screening quality, and health care delivery. Together, the new Unit can efficiently evaluate the full cervical cancer screening and follow-up - process, put screening actions within the context of comprehensive health care data, and lead PROSPR collaborative studies, such as those described in the Research Plan, that can evaluate the comparative effectiveness of different screening strategies, identify causes of screening failures, and examine the impact of HPV vaccination on screening uptake and outcomes.

Public Health Relevance

Screening can reduce cervical cancer incidence and mortality in clinical trials. However, the real practice of screening in a community based population differs from what can be achieved in trials. Characterizing potential failures of the screening process and developing screening strategies tailored to personal risk offer substantial potential for optimizing screening schedules/methods and decreasing cervical cancer deaths.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-B (M2))
Program Officer
Parker, Tonya
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Kaiser Foundation Research Institute
United States
Zip Code
Jensen, Christopher D; Doubeni, Chyke A; Quinn, Virginia P et al. (2015) Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol 13:739-46
Tiro, Jasmin A; Kamineni, Aruna; Levin, Theodore R et al. (2014) The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev 23:1147-58
Lee, Jeffrey K; Liles, Elizabeth G; Bent, Stephen et al. (2014) Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 160:171
Corley, Douglas A; Jensen, Christopher D; Marks, Amy R et al. (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370:1298-306
Doubeni, Chyke A (2014) The impact of colorectal cancer screening on the US population: is it time to celebrate? Cancer 120:2810-3
Corley, Douglas A; Jensen, Christopher D; Marks, Amy R et al. (2013) Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol 11:172-80
Lee, Jeffrey K; Levin, Theodore R; Corley, Douglas A (2013) The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? Clin Gastroenterol Hepatol 11:204-7
Levin, Theodore R (2012) The importance of choosing colorectal cancer screening tests: comment on "Adherence to colorectal cancer screening". Arch Intern Med 172:582-3